OCT 03, 2020 9:32 PM PDT

Treating Gut-Leakiness

WRITTEN BY: Nouran Amin

A drug called tofacitinib, also called Xeljanz , was found to treat permeability defects in the intestines. Tofacitinib is an FDA-approved drug known to treat rheumatoid arthritis and ulcerative colitis.

Ulcerative colitis is an inflammatory bowel disease currently affecting 1 million Americans. It is a chronic disease causing leakiness in the large intestine.

Learn more:

"Our work could help improve identification of patients who will be better responders to this drug," says biomedical scientist Declan F. McCole at the University of California, Riverside.

The drug was found to reduce the expression "protein tyrosine phosphatase non-receptor Type 2," or PTPN2.

"Patients with the loss-of-function mutations in PTPN2 have an increased risk of inflammatory bowel disease," McCole said. "Our work improves our understanding of how this drug is useful for treating ulcerative colitis and suggests that patients with loss-of-function mutations in the PTPN2 gene may have a better response to tofacitinib. This could help with improved targeting of drug treatments to specific groups of patients."

Findings were published Journal of Crohn's and Colitis.

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 20, 2022
Drug Discovery & Development
Vitamin E Stimulates Dendritic Cells, Boosts Immunotherapy Effectiveness
APR 20, 2022
Vitamin E Stimulates Dendritic Cells, Boosts Immunotherapy Effectiveness
Dendritic cells play an important role in the immune system. Specifically, they help gather up antigen-presenting cells ...
JUN 06, 2022
Drug Discovery & Development
Express Media Service Q&A with Sheng Li, PhD., FUJIFILM Irvine Scientific
JUN 06, 2022
Express Media Service Q&A with Sheng Li, PhD., FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific sat down with Sheng Li, PhD, Program Manager, to speak about our rapid service for small-scal ...
JUN 06, 2022
Cannabis Sciences
Price and Convenience: Key Reasons Why People Continue to Buy Illegal Cannabis
JUN 06, 2022
Price and Convenience: Key Reasons Why People Continue to Buy Illegal Cannabis
A study published in the Journal of Studies on Alcohol and Drugs found that price and convenience are the two main reaso ...
JUN 14, 2022
Coronavirus
Advances in Latest Coronavirus Research in the 2022 Ongoing Labroots Virtual Event Series
JUN 14, 2022
Advances in Latest Coronavirus Research in the 2022 Ongoing Labroots Virtual Event Series
Labroots hosted its 3rd annual Coronavirus Conference Virtual Event Series on May 4, 2022. The speaker roster for this f ...
JUN 23, 2022
Cannabis Sciences
The Latest Research on Cannabis Social Equity Programs
JUN 23, 2022
The Latest Research on Cannabis Social Equity Programs
Cannabis social equity programs are designed to increase licensure and employment opportunities for lower income and BIP ...
JUN 24, 2022
Drug Discovery & Development
Pain Medications with High Abuse Potential More Likely to Achieve Approval
JUN 24, 2022
Pain Medications with High Abuse Potential More Likely to Achieve Approval
Researchers found that pain medications with a high potential for abuse are more likely to be approved than medications ...
Loading Comments...